Preparation of Low Molecular Weight Polyglutamic Acid and Its Application in Targeting Ophthalmic Prodrug

Zhuo CHEN,Rui SHI,Li-yu TAN,Li-na WU,Qun-jie BI,Rui XIA,Lei ZHANG
DOI: https://doi.org/10.3969/j.issn.1671-0460.2016.12.025
2016-01-01
Abstract:Large molecular weight drugs cannot be absorbed by human corneas. In order to minimize the side effects caused by absorption into eyeball trough cornea in the application of the highly toxic Mitomycin C in ocular surface diseases, PGA derivative macromolecule prodrug PGA-MMC was designed. To reduce the package wrapping effect on MMC using the chain-like macromolecules modifying such as PGA, which can make the pesticide effect reduce, PGA was first quantitative hydrolyzed to get lower molecular weight PGA(1~5 k).And then series of low molecular weight PGA-MMC was synthesized .
What problem does this paper attempt to address?